Skip to main content
PLOS One logoLink to PLOS One
. 2026 Jan 13;21(1):e0326469. doi: 10.1371/journal.pone.0326469

Methamphetamine use disorder, perceived impacts, and associated factors among adults receiving care at Sri Lanka’s National Institute of Mental Health: An analytical cross-sectional study

N A A I Nishshanka 1,#, T N L Samarathunga 1,, S W Inoka 1,, R Suharna 1,, Dewarahandhi Kavishka Madushan De Silva 2,#, Kumarasinghe Arachchigey Sriyani 1,*
Editor: Nicholas Aderinto Oluwaseyi3
PMCID: PMC12798982  PMID: 41529069

Abstract

Methamphetamine addiction poses a growing public health challenge in Sri Lanka, yet limited research explores its impacts on the addicted population. This study aimed to assess the severity, patterns, and perceived impacts of methamphetamine addiction among adult patients at the National Institute of Mental Health (NIMH), Angoda, Sri Lanka. An analytical cross-sectional study was conducted among adult clients (aged >18 years) diagnosed with methamphetamine use disorder according to DSM-5 criteria at NIMH, Sri Lanka. A sample of 427 participants was recruited through purposive sampling. Data were collected using a structured, self-developed, validated, interviewer-administered questionnaire covering sociodemographic details, addiction severity (DSM-5 criteria), consumption patterns, impacts, and reasons for use. Descriptive statistics were analyzed using SPSS version 26. All participants (100%) responded to the survey. Among participants, 93.7% were male, and 65.3% were aged 18–30 years. The majority resided in urban (57.9%) or semi-urban (36.1%) areas. Addiction severity was categorized as mild (29%), moderate (38.6%), and severe (32.3%). Most (65.3%) initiated methamphetamine use between 21–30 years. Smoking (52.7%) and snorting (44.9%) were common methods of use, with peer pressure (48.9%) cited as the primary reason for initiation. The most cited physical impacts were weight loss (38.8%) and loss of appetite (37.2%), while irritability (28.8%) and interpersonal relationship problems (50.8%) were cited as common mental and social perceived impacts, respectively. Findings reveal that young urban males are predominantly affected by methamphetamine addiction, with moderate to severe dependence common. methamphetamine addiction severity was associated with living arrangement, monthly income, living area, age of onset, frequency of consumption, method of consumption, and accessibility (p < 0.05). Peer influence and easy accessibility were significant contributing factors. The physical, mental, and social health impacts emphasize the urgent need for comprehensive intervention strategies focusing on prevention, early detection, and integrated rehabilitation services at the national level.

Introduction

Methamphetamine is a potent central nervous system stimulant known for its strong addictive potential, which poses a critical challenge to global public health, particularly in low- and middle-income countries, where access to treatment and harm-reduction services remains limited [1,2]. The global count of amphetamine users has surged past 27 million in 2020 [3]. According to the 2021 National Survey on Drug Use and Health (NSDUH), More than 16.8 million people aged 12 or older used methamphetamine at least once during their lifetime [4].

This global trend is reflected in Asia, where methamphetamine use has significantly increased in recent years. Thailand and the Philippines were reported as the highest-rated methamphetamine prevalence in Asia [4]. In Sri Lanka, the drug abuse landscape is shifting, with methamphetamine becoming a prevalent concern [5]. In 2022, Methamphetamine was ranked as the third most commonly abused substance in Sri Lanka [6]. That year, 22,631 individuals were detained for methamphetamine-related offenses, and approximately 241 kg of the drug was seized [7]. By 2023, the number of arrests had risen to 26,096, an increase of roughly 15.3% highlighting the intensifying nature of the problem [8]. This report also underscored the gender disparity, with an overwhelmingly male representation, as 99.65% of individuals seeking treatment identified as male [7].

The reasons for methamphetamine use are complex and multifactorial. For most users, it serves as a performance enhancer, temporarily boosting energy, alertness, and concentration, fostering its use among adults engaged in high-pressure environments [9]. Moreover, social factors, including peer influences, cultural acceptance, and the accessibility of the drug, contribute to its appeal [6]. Several users also reported that past experiences of trauma, mental health issues, and familial drug use histories elevate the likelihood of methamphetamine use [10]. However, the motivations behind methamphetamine use were not clear in the Sri Lankan context.

Methamphetamine addiction affects individuals across physical, psychological, and social domains [11]. Physiologically, chronic use leads to significant cardiovascular problems, including increased heart rate and blood pressure, which can culminate in cardiovascular collapse [12]. Other than that, users also reported weight loss, dental issues colloquially known as “meth mouth,” and skin infections due to increased scratching and neglect of personal hygiene [13]. Psychologically, users reported a range of mental health issues including immediate euphoria coupled with anxiety, depression, and psychosis [14]. Cognitive impairments, including poor decision-making and impulse control, are often associated with changes in prefrontal cortex function [15]. Moreover, the cycle of withdrawal enhances the psychological burden; users experience a range of withdrawal symptoms, including dysphoria, insomnia, and intense drug cravings, which can perpetuate the cycle of addiction [16].

Moreover, methamphetamine addiction devastates interpersonal relationships and disrupts family dynamics, leading to heightened social stigma against users and their families [17]. Compulsive behaviors due to methamphetamine addiction can lead users to engage in criminal activities, high-risk sexual behaviors, which complicates the public health efforts [17,18].

Despite the rising prevalence of methamphetamine use in Sri Lanka and its well-documented socio-health impacts globally, there is a critical lack of detailed, community-based research exploring the local dynamics of use. Specifically, existing data are largely drawn from arrest records and generalized treatment statistics, which fail to capture the nuanced motivations, behavioral patterns, and perceived health consequences experienced by individuals using methamphetamine. Without such context-specific evidence, it is difficult to develop targeted interventions, policy responses, or harm-reduction strategies that are culturally and socially appropriate. In light of this gap, the current study seeks to generate in-depth, empirical insights into methamphetamine addiction among adults in Sri Lanka.

The specific objectives are to:

  • assess the severity and patterns of methamphetamine use;

  • determine the prevalence and types of polydrug use among methamphetamine users;

  • explore self-reported motivations for methamphetamine use;

  • examine users’ perceptions of the perceived physical, psychological, and social impacts of their drug use; and

  • identify factors associated with methamphetamine use

Materials and methods

Study design and setting

An analytical cross-sectional study was designed to assess methamphetamine addiction and its perceived impact on adult patients who were admitted to the National Institute of Mental Health (NIMH) at Mulleriyawa, Sri Lanka. NIMH is the country’s leading tertiary-level psychiatric care facility, providing inpatient, outpatient, and community-based services and serving as a referral center for substance use and mental health disorders. The study setting was selected due to its central role in addiction treatment nationally and its access to a diverse clinical population.

Population

The study’s target population consisted of all adult individuals (more than 18 years old) receiving treatment for methamphetamine addiction in the wards and day center at the NIMH during the study period. The decision to include only adults was based on several considerations. Firstly, the clinical presentation, patterns of substance use, psychosocial consequences, and treatment modalities for methamphetamine addiction differ markedly between adolescents and adults; thus, including only adults ensured a more homogeneous sample and increased the internal validity of the findings. Further, the focus on adult patients aligns with the core patient population of the NIMH’s addiction treatment services, enhancing the study’s relevance to national policy and clinical practice.

Both male and female adult individuals who were diagnosed with methamphetamine substance abuse disorder according to DSM-5 criteria (F15.10, F15.15, and F15.20) as confirmed by consultant psychiatrists or psychiatric medical officers using structured clinical interviews and medical records and were currently receiving treatments were included in the current study, while individuals with cognitive impairment, withdrawal symptoms and acute intoxication of methamphetamine were excluded from the study. Withdrawal symptoms were identified through medical records and clinical observation by attending clinicians prior to recruitment.

Sampling and sample size

The sample size for the study was determined using Daniel’s sample size calculation formula. Assuming a 95% confidence level (Z = 1.96), a prevalence (P) of 50%, and a precision (d) of 0.05, the calculated sample size was 384 [19]. To account for a potential 10% non-response rate (d), the sample size was adjusted using the formula N = n/1 − d, resulting in a final required sample size of 427 participants. The list of eligible patients was identified with the support of clinical staff using ward and day center admission logs and verified through medical records. Clinical staff initially screened patients based on diagnosis and treatment status. Participants were then recruited using a purposive sampling technique based on the predefined inclusion and exclusion criteria because the population represents a specific subgroup within the broader psychiatric patient population.

Data collection tool

A structured, interviewer-administered questionnaire was utilized to collect the data. It was developed by referring to existing literature related to substance abuse and methamphetamine addiction [2024]. It was comprised of four sections. The first section of the questionnaire was dedicated to obtaining participants’ socio-demographic data, which had ten items including age, gender, ethnicity, civil status, family status, educational level, occupation, monthly income, residence area, and province of living. The second section assessed the severity of addiction according to routinely used DSM-5 criteria confirmed by consultant psychiatrists or psychiatric medical officers [25]. It consisted of 11 items on symptoms of addiction, and the level of severity was categorized as mild, moderate, and severe according to the number of symptoms present with the addicted individual (mild = 2 − 3, moderate = 4 − 5, severe = 6 − 11) [25]. The third section of the questionnaire included self-developed, nine items to determine the pattern of methamphetamine consumption, including age of initiation, method of use, frequency of use, accessibility to methamphetamine, last use, person who introduced methamphetamine, daily expenditure to use methamphetamine, and use of other substances (polydrug use). In addition, three open-ended items were used to collect information regarding the physical, psychological, and social impact of methamphetamine use. The last section of the questionnaire included self-reported reasons (10 items with ‘yes’ or ‘no’ responses) for methamphetamine consumption.

The content validity of the questionnaire was ensured with experts’ opinions, including a consultant psychiatrist, a nursing academic, and a trained psychiatric nurse, and necessary modifications were made. The questionnaire was pre-tested among ten patients who were being treated for methamphetamine addiction to improve its clarity and examine whether the respondents could understand the items they were expected to answer [26]. The questionnaire was finalized considering the participants’ opinions received during the pre-test. Specifically, participants in the pre-test provided feedback regarding the clarity and phrasing of certain items. Based on this input, we made minor revisions to simplify language and ensure better comprehension, particularly for items related to the frequency of use and perceived psychological effects. Patients who participated in the pre-test were not included in the main study.

Data collection

Data collection was commenced after obtaining ethical clearance for the study from the Ethics Review Committee of NIMH and permission from the relevant hospital authorities. Data were collected from 20th July 2023 to 20th October 2023. All selected patients were fully informed about the purpose, nature, risks, and benefits of the study verbally and through an information sheet and obtained written consent before their participation. Volunteer participation was encouraged. Data were collected by four investigators who had undergone a training session on data collection using an interviewer-administered questionnaire. It was done with strict adherence to patient privacy and confidentiality, ensuring that data collection did not interfere with the patient’s treatment or care within their ward setup or daycare center. Interrater reliability was assessed using Cohen’s Kappa, which yielded a value of 0.78 for the severity items and 0.85 for the self-reported reasons, indicating substantial agreement between the two raters. To ensure interrater reliability of perceived impact, two researchers independently coded the transcripts and then met to discuss discrepancies until consensus was reached, ensuring consistent application of codes.

Ethical considerations

Ethical approval for the study was obtained from the Ethics Review Committee of NIMH (ERC No: 205/03/2023). Permission to access the setting and participants was obtained from the Director of the NIMH and Consultant Psychiatrists. Although a formal capacity assessment was not conducted, only clinically stable participants, without cognitive impairment, and not in a state of acute intoxication or withdrawal, were approached for consent. Clinical staff ensured that participants were coherent, alert, and oriented during recruitment. Participants were eligible only if they; were alert, fully oriented to person, place, and time; demonstrated the ability to understand the study purpose and procedures; were able to paraphrase the information sheet in their own words; could weigh risks and benefits and express a voluntary decision without coercion. All interviews were conducted in Sinhala, or Tamil, depending on participant preference. Because some items included psychological symptoms and possible suicidal ideation, a distress management protocol was followed. If a participant exhibited signs of distress, disclosed suicidal thoughts, or requested support: the interview was paused immediately; the participant was referred to the on-site psychiatrist or duty medical officer; participation continued only if the clinician confirmed the participant could safely do so. No adverse events were reported during data collection.

All individuals were provided with detailed information about the study and gave written informed consent before participation. The consent procedure, including the criteria for participant inclusion, was reviewed and approved by the aforementioned Ethics Review Committee. Permission to withdraw from the study was granted to the participants, and anonymity and confidentiality of the participants were ensured.

Data analysis

The collected data were coded and entered into SPSS version 26 for the analysis. No missing data were reported in the dataset. The dataset was cleansed to detect any missing values or outliers. Data were descriptively analyzed for frequencies and percentages. Methamphetamine addiction was categorized into mild, moderate, and severe based on the DSM-5 established standard framework [24]. Chi-square and Fisher’s exact test were utilized to derive the associated factors for methamphetamine use severity. Given the exploratory and descriptive nature of this study, no formal correction for multiple testing was applied. However, the findings are interpreted cautiously, focusing on the strength and consistency of associations rather than statistical significance alone [27]. Open-ended responses were systematically analyzed using a thematic coding framework. Initial codes were developed inductively from the data and refined through iterative reading. Two independent researchers applied the codes, and discrepancies were resolved through discussion, with a third researcher providing arbitration when necessary. Each response could receive multiple codes. Themes were then organized hierarchically into broader categories to capture patterns across responses. The final codebook with operational definitions is provided in Supplementary File S1 Table, and exemplar quotes for each major theme are presented in Supplementary File S2 Table. Percentages for perceived impacts were calculated using the total sample (N = 427) as the denominator. Because multiple responses per participant were permitted, the summed percentages exceed 100%. Intercoder reliability was assessed using Cohen’s kappa for overall physical, psychological and social domains as reported as κ = 0.82.

Results

Sociodemographic characteristics of the participants

Out of the calculated sample size of 427, all responses were collected, yielding a 100% response rate. Table 1 presents the socio-demographic data of the participants. Of the sample, the majority were males (n = 400, 93.7%). Most of the participants were within the young adult age range of 18–30 years (n = 279, 65.3%). The findings revealed a diverse racial composition, with the Sinhala ethnic group being the most prominent, comprising 59% (n = 252) of the total participants. A total of 42.9%(n = 183) of respondents were single. A total of 59.5%(n = 254) of individuals had attained education up to the secondary level. Most of the participants (n = 292, 68.4%) resided in the Western Province, with a significant proportion from North Western Province (n = 61, 14.3%). The majority of participants resided in urban (n = 57.9%) and suburban (36.1%) areas in the country.

Table 1. Sociodemographic data of the participants (N = 427).

Characteristics Frequency (n) Percentage (%)
Age (Years)
 18-30 279 65.3
 31-40 101 23.7
 41-50 34 8
 51-60 13 3.0
Gender
 Male 400 93.7
 Female 27 6.3
Social status
 Married 150 35.1
 Single 183 42.9
 Widowed 06 1.4
 Divorced 22 5.1
 Separated 66 15.5
Education a
 Primary education 63 14.8
 Secondary education 254 59.5
 Tertiary/Higher education 65 15.2
 Vocational education 45 10.5
Ethnicity
 Sinhala 252 59.0
 Moor 105 24.6
 Tamil 70 16.4
Living with whom
 Family 323 75.6
 Alone 95 22.3
 Other 09 2.1
Monthly income (LKR) b
  < 20,000 66 15.5
 20,000–30,000 69 16.2
 30,0001–40,000 136 31.8
 40,001–50,000 90 21
  > 50,000 66 15.5
Living province
 Western province 292 68.4
 Southern province 29 6.8
 Sabaragamuwa province 03 0.7
 Eastern province 04 0.9
 Central province 21 4.9
 North Western province 61 14.3
 Northern province 17 4
Living area
 Urban 247 57.9
 Semi-urban 154 36.1
 Rural 26 6

aPrimary education – Grade 01 to Grade 05.

Secondary education – Grade 06 to Advanced level (A/L).

Tertiary/Higher education – Undergraduate and/or postgraduate.

Vocational education – Vocational training or technical education.

bLKR; Sri Lankan rupees.

Urban – Areas within municipal/urban councils with high population density and primarily commercial or residential development.

Semi-urban: Transitional areas with mixed residential and developing commercial features, located between urban and rural settings.

Rural: Areas characterized by low population density, predominantly agricultural or village-based environments.

Methamphetamine addiction severity and the pattern of addiction among the participants

The findings of the severity and patterns of methamphetamine addiction among participants are presented in Table 2. Addiction severity was categorized as mild (29%), moderate (38.6%), and severe (32.3%). This distribution indicates that a significant proportion of participants (over 70%) exhibit moderate to severe levels of addiction, suggesting a high treatment need within this population. The age of onset was predominantly between 21–30 years (65.3%), with smaller proportions starting at ages 12–20 (22.5%) and 31–40 (9.8%) years. Consumption frequency varied, with 48.2% using methamphetamine several days a week, 28.1% using it daily, and 22.3% using it weekly. The majority reported their last usage within a week (54.6%), while 22.7% had used it within a month. Smoking (52.7%) and snorting (44.9%) were the most common methods of consumption, with minimal use of injection (1.9%) or swallowing (0.5%). Most participants were introduced to methamphetamine by friends (83.8%), followed by relatives (11%). Accessibility to the substance was perceived as fairly easy (46.6%) or easy (36.5%) by the majority, while 5.6% found it difficult to access.

Table 2. Methamphetamine addiction severity and the pattern of addiction among the participants (N = 427).

Characteristics Frequency (n) Percentage (%)
Severity of addiction
 Mild 124 29
 Moderate 165 38.6
 Severe 138 32.3
Age of onset (years)
 12-20 96 22.5
 21-30 279 65.3
 31-40 42 9.8
 41-50 10 2.3
Frequency of consumption a
 Daily 120 28.1
 Several days in week 206 48.2
 Weekly 95 22.3
 Once in month 06 1.4
Last usage
 Within a week 233 54.6
 Within a month 97 22.7
 One month ago 66 15.5
 06 months ago 31 7.2
Method of consumption
 Smoking 225 52.7
 Swallowing (pill) 02 0.5
 Snorting 192 44.9
 Injection 08 1.9
Introduced by
 Friends 358 83.8
 Relatives 47 11
 Foreigner 10 2.3
 Family member 12 2.8
Accessibility b
 Difficult 24 5.6
 Fairly difficult 48 11.2
 Fairly easy 199 46.6
 Easy 156 36.5

aFrequency of methamphetamine use refers to participants’ typical pattern of consumption prior to admission, categorized as:

Daily: use every day or almost every day

Several days per week: use on 3–5 days per week

Weekly: use approximately once per week

Once per month: use about once monthly

bAccessibility refers to participants’ perceived ease of obtaining methamphetamine during their regular period of use, categorized as:

Easy: readily obtainable with minimal effort

Fairly easy: obtainable with some effort but not difficult

Fairly difficult: required moderate effort or limited availability

Difficult: hard to obtain or inconsistent access

Polydrug consumption

Out of the sample, 55 (12.9%) used methamphetamine alone while the rest of them (n = 372, 87.1%) used other drugs with methamphetamine. Among the polydrug users, multiple responses were possible: 164 (38.4%) reported consuming alcohol, 166 (38.9%) used cannabis, 128 (30%) used heroin, 131 (30.7%) used tobacco, and 111 (26%) reported using other drugs. The high prevalence of polydrug use indicates a complex pattern of substance dependence, which can intensify health risks, complicate treatment, and heighten the potential for social harm.

To explore the potential confounding effect of polydrug use, a stratified descriptive analysis was performed comparing methamphetamine-only users (n = 55; 12.9%) with polydrug users (n = 372; 87.1%). A higher proportion of methamphetamine-only users were classified as severely addicted (40%) compared to polydrug users (31.7%). Patterns of consumption also differed. Daily use was more common among methamphetamine-only users (41.8%) than among polydrug users (26.7%), while polydrug users more frequently reported using the drug several days per week.

Self-reported reasons for methamphetamine consumption

Participants were asked to cite the most probable reasons for their methamphetamine addiction, and individuals were allowed to cite one or more reasons. Table 3 presents the self-reported reasons for methamphetamine addiction among the participants. Peer pressure was the most frequently cited reason, with 48.9% acknowledging its influence. A smaller proportion (23.1%) reported the involvement of peers in drug-related businesses as a contributing factor. Family-related reasons, such as isolation from family (11.5%), lack of family closeness (9.1%), and lack of parental support (3.2%), were less commonly reported. Only 1.8% attributed their consumption to having parents who were drug abusers, and 1.1% cited excessive punishment. Work-related factors included maintaining attention and concentration (13.6%), increasing job productivity (10.5%), and coping with a heavy workload (2.5%).

Table 3. Self-reported reasons for methamphetamine addiction among the participants.

Reason Yes

n (%)
No

n (%)
Peer pressure 209 (48.9) 218 (51)
Peers are doing business related to ICEa 99 (23.2) 328 (76.8)
Isolation from familyb 49 (11.5) 378 (88.5)
Lack of parental support 14 (3.3) 413 (96.7)
Lack of family closenessc 39 (9.1) 388 (90.9)
Parents are drug abusers 8 (1.9) 419 (98.1)
Subjected to excessive punishment 5 (1.2) 422 (98.8)
To increase the productivity of the job 45 (10.5) 382 (89.5)
To keep attention and concentration on work 58 (13.6) 369 (86.4)
The heavy workload of the job 11 (2.6) 416 (97.4)

aICE – General name used for methamphetamine crystals.

bBehavioral or physical separation from family.

cEmotional dimension of absence of warmth and supportive bond.

Isolation from family: Physical or behavioural separation from family members (e.g., spending limited time at home, living away, or avoiding family interaction).

Lack of family closeness: Emotional distance or weak supportive bonds within the family (e.g., reduced warmth, trust, or connectedness).

Lack of parental support: Perceived inadequate guidance, supervision, emotional support, or involvement from parents.

Peers doing business related to methamphetamine: Friends or acquaintances involved in selling, distributing, or trafficking methamphetamine.

Excessive punishment: Experiences of harsh or punitive disciplinary practices in childhood or adolescence.

Perceived physical impact of methamphetamine

Self-reported physical impacts of methamphetamine addiction were illustrated in Fig 1A and 1B. Weight loss (38.8%) and loss of appetite (37.2%) were the most commonly reported physical impacts among participants. Dental problems were reported by 12.1%, while malaise and chest pain were reported by 6.3% each. Other notable impacts included cough (7.4%), dry mouth (5.1%), myalgia (5.6%), and excessive sweating (4.2%) were also mentioned. Less frequently reported issues included physical injuries, headaches, and muscle cramps (around 3.2%−3.9% each), hair loss (2.3%), and jaw clenching (1.1%). Muscle rigidity was the least reported, affecting only 0.4% of participants.

Fig 1. Heatmaps illustrating self-reported perceived physical impacts due to methamphetamine addiction.

Fig 1

(A) Percentage heatmap: Illustrates the relative percentages of self-reported perceived physical impacts due to methamphetamine addiction, with color gradients representing the percentage of perceived symptoms. Darker colors indicate a higher percentage of self-reported physical impact, while lighter colors indicate a lower percentage of perceived effects. (B) Frequency heatmap: Illustrates the relative frequency of self-reported perceived physical impacts due to methamphetamine addiction, with color gradients representing the frequency of perceived symptoms. Darker colors indicate a higher frequency of self-reported physical impact, while lighter colors indicate a lower frequency of perceived effects.

Perceived psychological/mental impact

The perceived psychological impacts of methamphetamine addiction are illustrated in Fig 2A and 2B. Irritability was the most frequently reported psychological symptom (28.8%), followed by delusions (24.8%) and hallucinations (22.9%). Sleep problems were also common, affecting 18.7% of participants. Anxiety and fearfulness (14.5%), feeling low (11.9%), and poor concentration and attention (8.4%) were notable issues. Suicidal thoughts or self-harm (7.9%), homicidal ideas (3%), and aggression (4.6%) were less frequently mentioned. Loss of interest (6.3%) and restlessness/agitation (1.1%) were among the least reported. These findings highlight significant mental health challenges, particularly irritability, psychotic symptoms, and anxiety-related issues, associated with methamphetamine use.

Fig 2. Heatmaps illustrating self-reported perceived psychological/mental impacts due to methamphetamine addiction.

Fig 2

(A) Percentage heatmap: Illustrates the relative percentages of self-reported perceived psychological/mental impacts due to methamphetamine addiction, with color gradients representing the percentage of perceived symptoms. Darker colors indicate a higher percentage of self-reported psychological/mental impact, while lighter colors indicate a lower percentage of perceived effects. (B) Frequency heatmap: Illustrates the relative frequency of self-reported perceived psychological/mental impacts due to methamphetamine addiction, with color gradients representing the frequency of perceived symptoms. Darker colors indicate a higher frequency of self-reported psychological/mental impact, while lighter colors indicate a lower frequency of perceived effects.

Perceived social impact of methamphetamine

The perceived social impacts of methamphetamine addiction are illustrated in Fig 3A and 3B. Interpersonal relationship problems and conflicts were the most frequently reported social impact, affecting 50.8% of participants. Financial problems were also common, reported by 32%, while stigmatization and social isolation were noted by 28.3%. Employment disruption was reported by 10%, and legal problems by 8.9%. Poor role performance affected 7.9%, and academic difficulties were the least reported, affecting only 2.5% of participants.

Fig 3. Heatmaps illustrating self-reported perceived social impacts due to methamphetamine addiction.

Fig 3

(A) Percentage heatmap: Illustrates the relative percentages of self-reported perceived social impacts due to methamphetamine addiction, with color gradients representing the percentage of perceived symptoms. Darker colors indicate a higher percentage of self-reported social impact, while lighter colors indicate a lower percentage of perceived effects. (B) Frequency heatmap: Illustrates the relative frequency of self-reported perceived social impacts due to methamphetamine addiction, with color gradients representing the frequency of perceived symptoms. Darker colors indicate a higher frequency of self-reported social impact, while lighter colors indicate a lower frequency of perceived effects.

Associated factors for methamphetamine use severity

Severity of methamphetamine use was significantly associated with living arrangement (p = 0.043), monthly income (p < 0.001), living area (p < 0.001), age of onset (p = 0.028), frequency of consumption (p < 0.001), method of consumption (p < 0.001), and accessibility (p < 0.001) (Table 4).

Table 4. Associated factors for methamphetamine use severity.

Characteristics Mild Moderate Severe p-value
Age (Years)
18-30 77 (27.6) 110 (39.4) 92 (33) 0.232*
31-40 26 (25.7) 42 (41.6) 33 (32.7)
41-50 15 (44.1) 08 (23.5) 11 (32.4)
51-60 06 (46.2) 05 (38.5) 02 (15.4)
Gender
Male 117 (29.3) 152 (38) 131 (32.8) 0.567
Female 07 (25.9) 13 (35.6) 07 (25.9)
Social status
Married 38 (25.3) 60 (40) 52 (34.7) 0.374*
Single 55 (30.1) 72 (39.3) 56 (30.6)
Widowed 01 (16.7) 02 (33.3) 03 (50)
Divorced 12 (54.5) 05 (22.7) 05 (22.7)
Separated 18 (27.3) 26 (39.4) 22 (33.3)
Education a
Primary education 25 (39.7) 23 (36.5) 15 (23.8) 0.187
Secondary education 65 (25.6) 107 (42.1) 82 (32.3)
Tertiary/Higher education 22 (33.8) 20 (30.8) 23 (35.4)
Vocational education 12 (26.7) 15 (33.3) 18 (40)
Ethnicity
Sinhala 68 (27) 94 (37.3) 90 (35.7) 0.369
Moor 31 (29.5) 45 (42.9) 29 (27.6)
Tamil 25 (35.7) 26 (37.1) 19 (27.1)
Living with whom
Family 93 (28.8) 119 (36.8) 111 (34.4) 0.043*
Alone 31 (32.6) 41 (43.2) 23 (24.2)
other 00 (0) 05 (55.6) 04 (44.4)
Monthly income (LKR) b
<20,000 37 (56.1) 23 (34.8) 06 (9.1) <0.001
20,000–30,000 18 (26.1) 34 (49.3) 17 (24.6)
30,0001–40,000 54 (39.7) 44 (32.4) 38 (27.9)
40,001–50,000 12 (13.3) 39 (43.3) 39 (43.3)
>50,000 03 (4.5) 25 (37.9) 38 (57.6)
Living area
Urban 53 (21.5) 95 (38.5) 99 (40.1) <0.001*
Semi-urban 54 (35.1) 66 (42.9) 34 (22.1)
Rural 17 (65.4) 04 (15.4) 05 (19.2)
Age of onset (years)
12-20 38 (39.6) 39 (40.6) 19 (19.8) 0.028*
21-30 74 (26.5) 106 (38) 99 (35.5)
31-40 08 (19) 18 (42.9) 16 (38.1)
41-50 04 (40) 02 (20) 04 (40)
Frequency of consumption
Daily 35 (29.2) 30 (25) 55 (45.8) <0.001*
Several days in week 55 (26.7) 85 (41.3) 66 (32)
Weekly 34 (35.8) 48 (50.5) 13 (13.7)
Once in month 00 (0) 02 (33.3) 04 (66.7)
Method of consumption
Smoking 50 (22.2) 95 (42.2) 80 (35.6) <0.001*
Swallowing (pill) 00 (0) 00 (0) 02 (100)
Snorting 74 (38.5) 68 (35.4) (26)
Injection 00 (0) 02 (25) (75)
Accessibility
Difficult 16 (66.7) 04 (16.7) 04 (16.7) <0.001*
Fairly difficult 18 (37.5) 14 (29.2) 16 (33.3)
Fairly easy 60 (30.2) 76 (38.2) 63 (31.7)
Easy 30 (19.2) 71 (45.5) 55 (35.3)

*Fisher’s exact test.

Discussion

The current study is the first study, to the best of our knowledge, investigating Methamphetamine addiction and its perceived impacts on adult individuals receiving treatment in a local context. By examining various physical, psychological, and social impacts of methamphetamine addiction, the study contributes new insights into the complexities of addiction within this local context.

As revealed in the present study, the distribution of participants indicates a marked concentration in the Western Province, followed by North Western Province may reflect a regional pattern of methamphetamine use and availability. The majority residing in urban and suburban areas suggest that methamphetamine addiction may be more commonly identified or reported in these settings, possibly due to higher drug availability. According to the Drug Related Statistics 2019 in Sri Lanka [28], the majority of drug-related arrests were reported from the Western Province, North Western Province, and Southern Province of Sri Lanka. While these findings support the current findings, they also highlight the need for broader surveillance and the necessity of prompt preventive strategies.

The male predominance found in the present study is aligned with existing literature, denoting that men are more likely to engage in high-risk substance use behaviors, including methamphetamine use [6,29]. Various cultural norms, social influences, and biological susceptibility may have contributed to this gender imbalance. In Sri Lankan culture, children and women are generally well protected within the family context, and substance use among women is strongly stigmatized by society’s behaviors [6]. This societal disapproval may contribute to the notably low prevalence of substance use among females. Consistent with previous studies [6], most of the study participants were aged between 18–30 years, and this highlights the vulnerability of young adults to use methamphetamine. Adulthood often involves significant transitions, including entering the workforce and pursuing higher education stress and increase susceptibility to substance use [30]. These findings emphasize the importance of targeted preventive measures for young populations. The diversity in ethnic groups in the study sample implies that methamphetamine addiction transcends demographic boundaries. While this distribution partly reflects the local population, it also highlights the necessity of implementing culturally competent preventive measures to protect young adults from methamphetamine addiction. Nearly two-fifths of the participants reported being single, while a considerable number of participants were separated from their spouses. This may indicate an association between methamphetamine addiction and disrupted family relationships, suggesting that substance use could be linked with marital instability [31]. Compared with the findings of the National Dangerous Drug Control Board report in 2022 [32], more methamphetamine -addicted individuals in the present study were separated (66 vs 12), and this suggests a possible link between methamphetamine use and family separation.

Addiction to methamphetamine

The findings on Methamphetamine addiction severity and patterns of use among participants reveal critical insights into the prevalence, onset, frequency, and influencing factors of methamphetamine use. As revealed in the present study, most of the participants had moderate levels of methamphetamine addiction, followed by 32.3% classified as severe and 29% as mild. This distribution suggests a significant proportion of users have progressed beyond mild addiction, highlighting the need for intensive intervention and rehabilitation programs tailored to different addiction severities. The present study findings demonstrated a high frequency of methamphetamine consumption. Nearly half reported use on several days per week, while 28.1% consumed it daily. This pattern suggests a high dependency risk, particularly among daily users. Additionally, more than half reported using methamphetamine within the past week. Prolonged methamphetamine use has been associated with various disorders in previous studies [33]. According to the Morbidity and Mortality Weekly Report published in the USA, 50% of persons using methamphetamine in the past year met diagnostic criteria for past-year methamphetamine use disorder [29]. Smoking and snorting are the most common methods of methamphetamine consumption in the present study. This finding is consistent with the report by the American Addiction Centre, most consumers reported the above methods of consumption [34]. A survey conducted in Los Angeles revealed that the most popular method of methamphetamine use among participants were smoking (74.8%), followed by snorting (65.4%) [35]. These routes of administration have been widely reported in the literature to be associated with more rapid drug absorption and a higher potential for dependence [36].

As revealed in the present study, the majority of participants were introduced to methamphetamine by friends, followed by relatives. The accessibility of methamphetamine is a considerable concern in the present study. As found a significant proportion of participants reported that methamphetamine was fairly easy to access, while more than one-third found it easily accessible. In contrast, only a small percentage considered it difficult to obtain. This issue was similarly noted in Los Angeles, where 41.1% of their participants perceived that it was easy to access methamphetamine around their neighborhood [35]. The perception of easy access to methamphetamine among treatment-seeking adults at NIMH is concerning as it may contribute to continued use or relapse within this group e [37]. While these observations cannot be generalized nationally, they highlight the importance of supporting patients within the communities where they live through targeted-context specific interventions that address the environmental factors reported by this population.

Self-reported reasons for methamphetamine addiction

The findings on self-reported reasons for methamphetamine addiction indicate that peer influence is the most significant factor, with nearly half of the participants citing peer pressure as the reason for their drug use. The current findings align with a South African study, which mentioned the same results, that friends were by far the most common people to introduce methamphetamine to the participants [38]. This concern highlights the strong role of peer influence in substance addiction, emphasizing the need for peer-focused prevention programs that address risky behaviors in social circles [39]. This highlights the strong role of social circles in substance initiation and suggests that prevention strategies should focus on peer-led education and awareness programs. Approximately one in four participants reported that their peers were involved in methamphetamine-related business, which could indicate exposure to drug distribution networks that encourage or normalize methamphetamine use. Family-related factors such as isolation from family, lack of family closeness, and lack of parental support were reported by a smaller proportion of participants. In agreement with present findings, a review study identified coping with family-related problems and psychological distress as common reasons for methamphetamine use [40]. Similarly, a small proportion of participants reported having parents who were drug users, and experiencing excessive punishment during childhood as reasons for their addiction. These findings suggest that although family dynamics may influence drug use, they are not the primary drivers of methamphetamine addiction in the study population [41]. Work-related reasons for methamphetamine use were reported by a small but notable percentage of participants. Approximately 13% used methamphetamine to maintain attention and concentration at work, while 10.5% reported using it to enhance job productivity. The association between substance use and work performance indicates the need for workplace mental health programs and stress management interventions to reduce reliance on drugs for job-related demands.

Polydrug use

Present findings indicate that while a small portion of participants exclusively use methamphetamine, the vast majority engage in polydrug use. These findings resonate with the findings of a previous study where polydrug consumption was very common among methamphetamine consumers [42]. This high rate of concurrent substance use underscores the complex nature of addiction, suggesting that individuals may use multiple drugs to achieve specific effects or to self-medicate varying psychological or physical needs. Within this polydrug subgroup, notable substances commonly used alongside methamphetamine include alcohol, cannabis, heroin, and tobacco, with a considerable percentage also reporting the use of other unspecified drugs. As revealed in a case series study in the local context, young adults consumed a mixture of substances, including alcohol, heroin, cannabis, and amphetamines [5]. As found in previous studies, polydrug use was associated with rule-breaking behavior [30], violent and traumatic behavior, physical and sexual abuse [5], and various other psychiatric disorders such as major depression, post-traumatic stress disorder, panic attacks, obsessive-compulsive disorder, and antisocial personality [43]. As cited by earlier [5], compared with mature adult brains, young adults are more vulnerable to drug-seeking behaviors due to the “pleasure-seeking behavior” of the young, immature brains [44]. The presence of polydrug use highlights the urgent need for integrated and context-specific treatment models that address the complexity of multiple substance dependencies. Effective withdrawal management requires improved clinical protocols and trained personnel to manage compound risks. There is a critical need for culturally adapted relapse prevention strategies and community-based follow-up services to support sustained recovery, especially in low-resource settings [45].

The very high prevalence of polydrug use in this sample (87%) presents important interpretive challenges when examining the impacts of methamphetamine. To address this, the present study conducted stratified analyses comparing methamphetamine -only users with polydrug users. Notably, methamphetamine -only users showed a higher proportion of severe addiction and a greater likelihood of daily use. These findings suggest that, within this clinical population, heavy or frequent methamphetamine use can occur independently of other substances. Many of the “perceived impacts,” such as aggression, irritability, interpersonal relationship problems, and loss of appetite, could be potentiated or confounded by the simultaneous use of depressants like alcohol and stimulants such as cannabis or tobacco. Similar findings were reported by Darke et al. [24] and Jayanthi et al. [46], who noted that in polydrug contexts, methamphetamine ’s direct neurotoxic and behavioral effects are often amplified or masked by other substances. Therefore, rather than attributing adverse outcomes solely to methamphetamine, it is more accurate to view them as the result of interactive or synergistic drug effects. This emphasizes the importance of future research employing stratified analyses or biological verification methods to isolate methamphetamine -specific consequences while accounting for concurrent substance use.

Perceived physiological impact of methamphetamine addiction

The findings highlight a range of self-reported physical impacts of methamphetamine use, demonstrating its potential to affect multiple bodily systems. The most frequently reported effects, including weight loss and loss of appetite, were commonly observed among users and may indicate a risk of nutritional deficiencies over time. These findings underscore the need for targeted nutritional interventions to address malnourishment and to restore metabolic balance in affected individuals [47]. Similarly, comprehensive dental care is essential as methamphetamine use has been commonly associated with notable oral health concerns [48]. Other symptoms, such as malaise, chest pain, cough, and excessive sweating, further demonstrate the extent of the influence of methamphetamine addiction on the human body.. As reported by Darke [23] methamphetamine addiction has been associated with physical harm, including toxicity, cardiovascular/cerebrovascular pathology, dependence, and blood-borne virus transmission.

Perceived psychological impacts

Previous studies have documented the psychological harm of methamphetamine addiction, including psychosis, depression, suicide, anxiety, and violent behaviors [23]. The present findings highlight range and severity of perceived psychological effects of methamphetamine use, offering insights into both short-term disturbances and long-term mental health challenges. Irritability was the most prevalent symptom, indicating increased emotional instability, which may be negatively affects interpersonal relationships and potentially lead to aggression or conflict [4951]. In addition, the high prevalence of delusions and hallucinations suggests a link between methamphetamine use and psychotic symptoms, which can emerge or intensify with frequent or prolonged use. Similarly, many studies have reported hallucinations as a frequently found psychotic symptom of chronic methamphetamine use [51,52]. Compared with previous studies, sleep problems were reported to a considerable extent in the present study, suggesting a connection between methamphetamine use and disturbed sleep-wake cycles [44,53]. These disturbances may contribute to fatigue, impaired judgment, and worsening mood swings [44]. Anxiety is more common among chronic methamphetamine users [44,51,54,55]. High levels of anxiety/ fearfulness and feeling low found in the present study highlight the drug’s ability to influence the emotional and psychological well-being of users. These issues, tied with poor concentration and attention, can have profound implications for daily functioning and quality of life, often interfering with work and education [56]. Of particular concern, suicidal thoughts or self-harm behaviors were reported by 7.9% of participants [52]. Although homicidal ideas, aggression, and loss of interest were comparatively lower, these rates still signify a substantial risk that emphasizes the need for comprehensive mental health screenings and providing necessary treatments.

Perceived social impact of methamphetamine addiction

The most prominent social impact reported was interpersonal relationship problems and conflict affecting, over half of the participants. This finding underscores that methamphetamine use may exert on personal connections, contributing to family disputes, breakdowns in friendships, and overall social dysfunction. Financial problems were another commonly reported challenge, suggesting a potential association between methamphetamine use and economic strain. Additionally, stigmatization and social isolation reflect the broader social barriers and negative attitudes that individuals with substance use disorders often face, which can hinder access to support and worsen mental health outcomes. Although employment disruption (10%, legal problems (8.9%), poor performance, and academic difficulties were less frequently reported, they still indicate that methamphetamine addiction may affect nearly every aspect of daily life, from maintaining steady employment to fulfilling societal and personal responsibilities. As reported previously, chronic use of methamphetamine causes social isolation due to social withdrawal [21].

Factors associated with methamphetamine use

In the present study, several socio-demographic and contextual factors were significantly associated with the severity of methamphetamine use, including monthly income, living area, age of onset, frequency and method of consumption, accessibility, and living arrangements. Notably, individuals with higher income and those residing in urban areas showed a greater likelihood of severe use, which contrasts with studies from the United States and other settings where low socioeconomic status and rural residence were more strongly linked to methamphetamine use and related harms [57,58]. This difference may reflect local factors, including greater drug availability and stronger enforcement activity in urban areas as well as the NIMH catchment pattern, affordability of the drug among higher-income users, and potential referral or reporting variations. These contextual influences may shape the associations observed among treatment-seeking adults at NIMH [59]. Earlier onset of use (12–20 years) in the present study sample was associated with milder severity, diverging from global evidence that early initiation is associated with more severe dependency and poorer outcomes [57]. This discrepancy may indicate cohort or recall differences, or that early initiators in this sample have not yet escalated to severe use. In contrast, present findings on frequency and method of consumption aligned with previous research, showing that daily use, smoking, and especially injection were strongly associated with severe dependence [57,58] Furthermore, reports of easy access to methamphetamine among participants coincided with more severe use patterns, which aligns with previous observations that drug availability may be linked to both initiation and escalation in other contexts [60]. Overall, while some associations replicate international findings, others highlight unique local dynamics that underscore the importance of context-specific interventions for prevention and harm reduction.

Strengths and limitations

The present study has several strengths, including a 100% response rate and comprehensive coverage of the impact of methamphetamine. However, it also has certain limitations. The descriptive cross-sectional design restricts causal inference, and findings represent associations rather than cause–and–effect relationships. Reliance on self-reported data may introduce recall social desirability bias, such as under- or over-reporting. Therefore, it should be interpreted with caution. Additionally, because all participants were recruited from a single tertiary mental health institution, the results may not fully reflect community users or those untreated for methamphetamine use disorder. The study also did not control for potential confounding from polydrug use or comorbid psychiatric conditions, which may have influenced reported impacts.

Future studies should employ longitudinal and multicenter designs, include biochemical verification of substance use, and explore qualitative dimensions to better understand user experiences.

Conclusions

This study provides empirical evidence on the growing public health concern of methamphetamine addiction in Sri Lanka, particularly among young adult males. It identifies the high prevalence of moderate to severe addiction, influenced predominantly by peer pressure and facilitated by easy access to methamphetamine. Often accompanied by polydrug use and the physical, psychological, and social repercussions, including disrupted family relationships and workplace challenges, underscore the multifaceted impact of methamphetamine use. The severity of methamphetamine use is associated with living arrangements, monthly income, living area, age of onset, frequency of consumption, method of consumption, and accessibility. The study bridges a significant research gap by providing localized insights into patterns and consequences of methamphetamine addiction. These findings highlight an urgent need for targeted, youth-focused prevention strategies, particularly peer-led and culturally tailored interventions. Additionally, tighter regulation and enforcement to disrupt methamphetamine supply chains are essential to curb availability and mitigate further harm.

Supporting information

S1 Table. 1, 2, 3 codebook.

(DOCX)

pone.0326469.s001.docx (24.6KB, docx)
S2 Table. 1, 2, 3 exemplar quotes.

(DOCX)

pone.0326469.s002.docx (18.6KB, docx)

Acknowledgments

The authors would like to thank all the participants and the NIMH clinical staff and administration officers.

Data Availability

All data files are available from the figshare database https://doi.org/10.6084/m9.figshare.29816636.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.World Drug Report 2020. 2020. Available from: https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf [Google Scholar]
  • 2.Farhoudian A, Razaghi E, Hooshyari Z, Noroozi A, Pilevari A, Mokri A, et al. Barriers and facilitators to substance use disorder treatment: An overview of systematic reviews. Subst Abuse. 2022;16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.EU Drug Market: Amphetamine Global context. www.euda.europa.eu [Internet]. Europa.eu. 2024. Available from: https://www.euda.europa.eu/publications/eu-drug-markets/amphetamine/global-context_en [Google Scholar]
  • 4.Mahir ILM, Wazeema TMF. Social Aspects of Drug Addiction in Sri Lanka. J Politics Law. 2020;13(2):54. [Google Scholar]
  • 5.Raveendran S, Hulathduwa SR. Changing Patterns in the Types and Methods of Abuse of Illegal Drugs in Sri Lanka: A Study Based on Five Recent Case Series. Medico-Legal J Sri Lanka. 2021;9(1):37. [Google Scholar]
  • 6.Jayamaha AR, Dharmarathna ND, Herath ND, Ranadeva ND, Fernando MM, Samarasinghe KL, et al. The pattern of substance use and characteristics of the individuals enrolled in residential treatment at selected rehabilitation centers in Sri Lanka: A descriptive cross-sectional study. Subst Abuse. 2022;16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.National Dangerous Drugs Control Board. 2022.
  • 8.National Dangerous Drugs Control Board Report. 2023.
  • 9.Tucker MG, Kekulawala S, Kent M, Mostafa S, Harvey R. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report. J Med Case Rep. 2016;10(1):242. doi: 10.1186/s13256-016-1031-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lecomte T, Mueser KT, MacEwan WG, Laferrière-Simard M-C, Thornton AE, Buchanan T, et al. Profiles of individuals seeking psychiatric help for psychotic symptoms linked to methamphetamine abuse – baseline results from the MAPS (methamphetamine and psychosis study). Mental Health Subst Use. 2010;3(3):168–81. doi: 10.1080/17523281.2010.504645 [DOI] [Google Scholar]
  • 11.Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11–21. doi: 10.1016/j.drugalcdep.2014.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Abbruscato TJ, Trippier PC. DARK Classics in Chemical Neuroscience: Methamphetamine. ACS Chem Neurosci. 2018;9(10):2373–8. [DOI] [PubMed] [Google Scholar]
  • 13.İvecen B, Gokdemir O. Methamphetamine Addiction. DAHUDER Med J. 2022;2(4):98–101. [Google Scholar]
  • 14.Stuart AM, Baker AL, Denham AMJ, Lee NK, Hall A, Oldmeadow C, et al. Psychological treatment for methamphetamine use and associated psychiatric symptom outcomes: A systematic review. J Subst Abuse Treat. 2020;109:61–79. doi: 10.1016/j.jsat.2019.09.005 [DOI] [PubMed] [Google Scholar]
  • 15.Jiang X, Tian Y, Zhang Z, Zhou C, Yuan J. The counterproductive effect of right anodal/left cathodal transcranial direct current stimulation over the dorsolateral prefrontal cortex on impulsivity in methamphetamine addicts. Front Psychiatry. 2022;13:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dolatshahi B, Farhoudian A, Falahatdoost M, Tavakoli M, Rezaie Dogahe E. A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers. Int J High Risk Behav Addict. 2016;5(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Massah O, Shishehgar S. Methamphetamine dependence, psychological well-being, criminality and high risk sexual behaviors in female-only methadone services in Tehran and Karaj, Iran. Iran J Psychiatry Behav Sci. 2018;12(2). [Google Scholar]
  • 18.Farhoudian A, Dolatshahi B, Falahatdoost M, Tavakoli M, Farhadi MH. A Qualitative Study on Methamphetamine-Related Sexual High-Risk Behaviors in an Iranian Context. Int J High Risk Behav Addict. 2016;6(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Daniel WW. Biostatistics: a foundation for analysis in the health sciences. 7th ed. Willey; 1999. p. 324–6. [Google Scholar]
  • 20.Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, et al. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities. JAMA Netw Open. 2022;5(8):e2226544. doi: 10.1001/jamanetworkopen.2022.26544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Homer BD, Solomon TM, Moeller RW, Mascia A, DeRaleau L, Halkitis PN. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol Bull. 2008;134(2):301–10. doi: 10.1037/0033-2909.134.2.301 [DOI] [PubMed] [Google Scholar]
  • 22.Franke AG, Neumann S, Proebstl L, Kamp F, Hager L, Manz K, et al. Psychiatric comorbidity and psychopathology of methamphetamine users—are there gender differences? Int J Ment Health Addict. 2023;21(4):2632–49. [Google Scholar]
  • 23.Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253–62. doi: 10.1080/09595230801923702 [DOI] [PubMed] [Google Scholar]
  • 24.Diagnostic and statistical manual of mental disorders - fifth edition text revision. 2022. [Google Scholar]
  • 25.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. [Google Scholar]
  • 26.Hilton CE. The importance of pretesting questionnaires: a field research example of cognitive pretesting the Exercise referral Quality of Life Scale (ER-QLS). Int J Soc Res Methodol. 2017;20(1):21–34. [Google Scholar]
  • 27.Taber KS. The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education. Res Sci Educ. 2018;48(6):1273–96. [Google Scholar]
  • 28.National Dangerous Drugs Control Board. Current drugs prevalence and abuse situation in Sri Lanka. Colombo: National Dangerous Drugs Control Board; 2019. [Google Scholar]
  • 29.Jones CM, Compton WM, Mustaquim D. Morbidity and Mortality Weekly Report Patterns and Characteristics of Methamphetamine Use Among Adults-United States, 2015-2018 [Internet]. 2020. Available from: https://www.cdc.gov/mmwr/mmwr_continuingEducation.html [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.McClelland GM, Elkington KS, Teplin LA, Abram KM. Multiple substance use disorders in juvenile detainees. J Am Acad Child Adolesc Psychiatry. 2004;43(10):1215–24. doi: 10.1097/01.chi.0000134489.58054.9c [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013;21(4):S73–6. doi: 10.1016/j.jfda.2013.09.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.National Dangerous Drugs Control Board. Handbook of Drug Abuse Information in Sri Lanka 2022. Bhadrani Senanayake, Jayani Ranasinghe, Hiruni Wathsala, Thamara Darshana, editors. Research Division, Ministry of Public Security. [Google Scholar]
  • 33.Payer DE, Nurmi EL, Wilson SA, McCracken JT, London ED. Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry. Transl Psychiatry. 2012;2(2):e80. doi: 10.1038/tp.2011.73 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Coffin PO, Suen LW. Methamphetamine Toxicities and Clinical Management. NEJM Evid. 2023;2(12):EVIDra2300160. doi: 10.1056/EVIDra2300160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wi A. Methamphetamine use and public perceptions in Los Angeles County: findings from the 2022 community needs assessment. 2024.
  • 36.Kiluk BD, Babuscio TA, Nich C, Carroll KM. Smokers versus snorters: do treatment outcomes differ according to route of cocaine administration? Exp Clin Psychopharmacol. 2013;21(6):490–8. doi: 10.1037/a0034173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Li D, Wang D, Tian Y, Chen J, Zhu R, Li Y, et al. Association between drug craving and aggression in Chinese male methamphetamine-dependent patients with and without depressive symptoms. Eur Arch Psychiatry Clin Neurosci. 2024;274(2):461–9. [DOI] [PubMed] [Google Scholar]
  • 38.Hobkirk AL, Watt MH, Myers B, Skinner D, Meade CS. A qualitative study of methamphetamine initiation in Cape Town, South Africa. Int J Drug Policy. 2016;30:99–106. doi: 10.1016/j.drugpo.2015.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.De Silva DKM, Dissanayake DM, Thilakarathna PK, Kumara GL, Shamen UJ, Dharmasiri WD, et al. Energy Drinks Consumption Among Undergraduate Students at a Sri Lankan State University. 2025;4(1):20–37. https://doi.org/10.4038/sljn.v4i1.84 [Google Scholar]
  • 40.Hançer Tok H, Tokur Kesgin M. Reasons for using methamphetamine: Systematic review. Arch Psychiatr Nurs. 2024;52:147–54. doi: 10.1016/j.apnu.2024.07.007 [DOI] [PubMed] [Google Scholar]
  • 41.Ram D. Family dynamics may influence an individual’s substance use abstinence self-efficacy. J Addict Prev Med. 2017;02(01). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bobashev GV, Warren LK. National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health. Drug Alcohol Depend. 2022;238:109553. doi: 10.1016/j.drugalcdep.2022.109553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zande T, Kopak A, Hoffmann N. Multiple diagnoses in the context of parallel epidemics: methamphetamine, opioid use disorder and psychiatric conditions. J Public Ment Health. 2024;23(1):4–13. doi: 10.1108/jpmh-09-2023-0076 [DOI] [Google Scholar]
  • 44.McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100(9):1320–9. doi: 10.1111/j.1360-0443.2005.01160.x [DOI] [PubMed] [Google Scholar]
  • 45.International Standards for the Treatment of Drug Use Disorders: Revised Edition Incorporating Results of Field-Testing. World Health Organization and United Nations Office on Drugs and Crime; 2020.
  • 46.Jayanthi S, Daiwile AP, Cadet JL. Neurotoxicity of methamphetamine: Main effects and mechanisms. Exp Neurol. 2021;344:113795. doi: 10.1016/j.expneurol.2021.113795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.García-Estrada J, Luquin S, Pesqueda-Cendejas K, Ruiz-Ballesteros AI, Campos-López B, Meza-Meza MR, et al. Malnutrition in Substance Use Disorders: A Critical Issue in Their Treatment and Recovery. Healthcare (Basel). 2025;13(8):868. doi: 10.3390/healthcare13080868 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Shetty V, Harrell L, Murphy DA, Vitero S, Gutierrez A, Belin TR, et al. Dental disease patterns in methamphetamine users: Findings in a large urban sample. J Am Dent Assoc. 2015;146(12):875–85. doi: 10.1016/j.adaj.2015.09.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Love S, Rowland B, Stefanidis KB, Davey J. Contemporary drug use and driving patterns: A qualitative approach to understanding drug-driving perceptions from the context of user patterns. Policing J Policy Pract. 2023;17. [Google Scholar]
  • 50.Uhlmann A, Ipser JC, Wilson D, Stein DJ. Social cognition and aggression in methamphetamine dependence with and without a history of psychosis. Metab Brain Dis. 2018;33(2):559–68. [DOI] [PubMed] [Google Scholar]
  • 51.Love S, Nicolls M, Rowland B, Davey J. The impact of methamphetamine use and dependence: A systematic review on the cognitive-behavioural implications for road safety. Transp Res F Traffic Psychol Behav. 2024;103:480–99. doi: 10.1016/j.trf.2024.05.002 [DOI] [Google Scholar]
  • 52.McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction. 2014;109(5):798–806. doi: 10.1111/add.12474 [DOI] [PubMed] [Google Scholar]
  • 53.Su H, Chen T, Jiang H, Zhong N, Du J, Xiao K, et al. Intermittent theta burst transcranial magnetic stimulation for methamphetamine addiction: A randomized clinical trial. Eur Neuropsychopharmacol. 2020;31:158–61. doi: 10.1016/j.euroneuro.2019.12.114 [DOI] [PubMed] [Google Scholar]
  • 54.Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, et al. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010;105(10):1809–18. doi: 10.1111/j.1360-0443.2010.03066.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wang G, Shi J, Chen N, Xu L, Li J, Li P, et al. Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS One. 2013;8(7):e68791. doi: 10.1371/journal.pone.0068791 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Proebstl L, Krause D, Kamp F, Hager L, Manz K, Schacht-Jablonowsky M, et al. Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence. Psychiatry Res. 2019;281:112599. doi: 10.1016/j.psychres.2019.112599 [DOI] [PubMed] [Google Scholar]
  • 57.Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults — United States, 2015–2018. MMWR Morb Mortal Wkly Rep. 2020;69(12):317–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. 2021;78(12):1329–42. doi: 10.1001/jamapsychiatry.2021.2588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Rastegari A, Haghdoost AA, Baneshi MR, Azizian M, Mehrolhassani MH. Identifying the Factors Affecting Methamphetamine Use: A Scoping Review. Med J Islam Repub Iran. 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Shahbazi Sighaldeh S, Zarghami F, Shahryari A, Mohammadinia A, Ebrahimi M, Jorjani T, et al. A qualitative exploration of the factors associated with initiation to methamphetamine use in Iran. BMC Public Health. 2020;20(1):1773. doi: 10.1186/s12889-020-09908-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Nicholas Aderinto Oluwaseyi

8 Jul 2025

Dear Dr. Sriyani,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Nicholas Aderinto Oluwaseyi

Academic Editor

PLOS ONE

Journal Requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please describe in your methods section how capacity to provide consent was determined for the participants in this study. Please also state whether your ethics committee or IRB approved this consent procedure. If you did not assess capacity to consent please briefly outline why this was not necessary in this case.

3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly.

4. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: 1) Although the authors indicate that the study site admits patients from allover the country, admissions are basically from the Western province and this limits the applicability of data to other regions of the country. The sample is highly selective.

2) The described physical and mental impacts cannot be attribute to methamphetamine, as most of them were on other psychoactive drugs or agents.

3) The physical effects described are very non specific. e.g weight loss (subjective or objective), cough (was it based on the duration or severity), anorexia

Reviewer #2: Comments to the Editor

Dear Editor,

Thank you for the opportunity to review this manuscript. The study addresses an important and underexplored topic: the patterns, severity, and impacts of Methamphetamine addiction among adults receiving treatment in Sri Lanka. While it provides useful local evidence, the manuscript would benefit from substantial revisions to strengthen its clarity, coherence, and scholarly contribution. Please find my detailed comments below.

Introduction

• The opening sentence is acceptable but could be made more impactful by highlighting why this stimulant poses a particular threat in low- and middle-income country contexts, where treatment and harm-reduction services are limited.

• The transition from global to Asian data is abrupt. Adding a bridging sentence would improve the flow (e.g., “This global trend is reflected in Asia, where…”).

• Ensure numerical comparisons are clear and impactful; for example, show percentage increases when comparing 2022 to 2023 arrest data.

• Some phrasings are redundant (e.g., “widespread effects that are multifaceted and interrelated…” could be simplified).

• When citing multiple sources, consider combining them for readability.

• The rationale for the study could be clearer: specify how this study will explore local motivations in depth.

• The research gap paragraph should be more assertive: e.g., “Despite rising prevalence, there is a critical lack of detailed, community-based research…”

• Split the aim statement into clear, bullet-pointed objectives for easy reading.

• Minor grammatical edits: use “aged 12 or older” instead of “age 12 or older”; merge repetitive sentences for conciseness.

Methods

• Important details on sampling and recruitment procedures are missing. How were participants identified and selected?

• Use consistent past tense for the study design description. Avoid repetition when describing the setting.

• Clarify how DSM-5 diagnoses were confirmed — by whom and based on what process?

• Explain how withdrawal symptoms were identified and excluded during recruitment.

• Confirm that the source for the DSM-5 criteria is cited correctly.

• For the pattern-of-use questions, indicate whether these items were validated or developed by the authors. If author-developed, how were they pre-tested and improved?

• You mention open-ended questions but do not explain how responses were coded and analyzed — this should be described briefly.

• Good to note the pre-test and Cronbach’s alpha; specify how feedback from the pre-test informed final revisions.

• In data collection, mention how many interviewers were involved and whether inter-rater reliability was checked.

• In data analysis, clarify that only descriptive statistics were planned if no inferential analysis was done; explain how missing data were handled.

• Ensure consistent tense and phrasing: e.g., “due to the population represents…” should be “because the population represents…”

it is not clear why data was only analyzed descriptively. Rigorous data analysis would benefit the study.

what confounding factors were detected and how were they controlled?

Results

• It is unclear why “Muslim” is classified as an ethnicity rather than a religious group — please clarify or adjust the categorization.

• The education level categories (primary, secondary, tertiary, higher, vocational) are not clearly defined — consider aligning with standard classifications.

• Use consistent past tense when reporting results.

• Ensure small percentages are formatted consistently.

• Tables are generally well-structured, but check for decimal alignment. Clarify in the polydrug use table that multiple responses were possible.

• Heatmaps should be correctly labeled in the text as “Figure 1A,” “Figure 1B,” etc., and figures should be cross-referenced appropriately.

• When reporting severity and patterns, add a line to interpret what the distribution implies.

• Small details: use “Separated” instead of “Separate” for social status. Clarify overlap between similar items such as “isolation from family” and “lack of family closeness.”

• Briefly interpret the significance of polydrug use and social impacts to guide the reader’s understanding.

Discussion

• The Discussion should more clearly compare the study’s findings with previous research, highlighting reasons for similarities and differences.

• Some points are repeated unnecessarily (e.g., male predominance, cultural stigma, physical impacts). Combine these for conciseness.

• Expand on the implications of polydrug use for treatment planning, withdrawal management, and relapse prevention in local contexts.

• For physical impacts, tie findings to specific clinical consequences (e.g., the need for nutritional or dental interventions).

• When citing other studies, integrate citations meaningfully: show how your results align with or differ from theirs.

• Limitations are acknowledged but could be stronger: note the reliance on self-reported data, the potential for under- or over-reporting, and the lack of generalizability due to the single-site setting.

• Highlight the strengths of the study (e.g., high response rate, comprehensive coverage of impacts).

• Offer recommendations for future research, such as using mixed methods or longitudinal designs.

Conclusion

• The conclusion should be more precise and actionable. Avoid generic phrases like “sheds light”; instead, state what this study adds empirically and how it informs policy and practice.

• Summarize clear, evidence-based recommendations: e.g., the need for peer-led prevention, youth-focused outreach, integrated mental health services, and stricter control of Methamphetamine supply chains.

Overall Recommendation

This study addresses an important gap and has merit. However, significant revisions are required to strengthen the introduction, clarify methods, ensure consistency in reporting, expand the discussion, and refine the conclusion. I therefore recommend major revision before the manuscript can be considered for publication.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Dr Ngozika Esther Ezinne

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Jan 13;21(1):e0326469. doi: 10.1371/journal.pone.0326469.r002

Author response to Decision Letter 1


3 Aug 2025

Dear Editor-In-Chief And Reviewers,

PLOS ONE,

We would like to sincerely thank you for the time and effort you have invested in reviewing our manuscript titled “Methamphetamine addiction and its perceived impact on adult clients at the National Institute of Mental Health, Sri Lanka: A descriptive cross-sectional study”. We appreciate the constructive feedback provided by the reviewers and editor, which has helped us improve the quality and clarity of our work.

Below, we provide detailed responses to each of the comments raised. All revisions have been made in the manuscript, with changes denoted as track changes (Both clean and track changed versions uploaded). We have addressed each point as follows:

Reviewer 1:

1. Although the authors indicate that the study site admits patients from allover the country, admissions are basically from the Western province and this limits the applicability of data to other regions of the country. The sample is highly selective - Response (Thank you very much for your consideration. The study purposively included all eligible adult clients diagnosed with methamphetamine use disorder admitted to NIMH during the study period, irrespective of their district of origin, ensuring clinical consistency. Nonetheless, since the majority of admissions to NIMH were from the Western Province, the sample may not fully represent the geographic diversity of methamphetamine users across Sri Lanka, and it was stated under the limitations of the study)

2. The described physical and mental impacts cannot be attributed to methamphetamine, as most of them were due to other psychoactive drugs or agents - Response (We appreciate the reviewer’s insightful observation regarding the potential confounding effect of polydrug use in attributing specific impacts to methamphetamine.

We agree that in a clinical sample where polydrug use is common, exclusive attribution of observed impacts to methamphetamine is scientifically challenging. However, we would like to clarify that our primary intention was to explore self-reported and perceived impacts associated with methamphetamine use among clients diagnosed with methamphetamine use disorder, rather than to establish causality.

Given that methamphetamine was the primary substance of use and the basis for admission in these clients, their perceived experiences remain highly relevant for clinical management and health education, despite potential contributions from other substances. Additionally, in real-world clinical and harm reduction contexts, it is often difficult to isolate the impacts of individual substances due to the high prevalence of concurrent substance use.)

3. The physical effects described are very nonspecific. e.g weight loss (subjective or objective), cough (was it based on the duration or severity), anorexia. Respone (We acknowledge that physical impacts such as weight loss, cough, and anorexia are nonspecific and can have multiple causes. However, in this study, data were collected through client self-reports during data collection, aiming to capture the perceived impacts experienced by clients diagnosed with methamphetamine use disorder during their use period, and this matter was clearly explained during the information-giving period for the patient. The intention was not to present these as clinical diagnostic findings but to document clients’ lived experiences, which are valuable for understanding patient perspectives in treatment and education planning. We have clarified this in the manuscript to reflect that the findings represent perceived, self-reported impacts, not objectively measured clinical outcomes.)

Reviewer 02

Introduction:

1. The opening sentence is acceptable but could be made more impactful by highlighting why this stimulant poses a particular threat in low- and middle-income country contexts, where treatment and harm-reduction services are limited.- Response (Accepted the comment, and the information was added at the end of the opening sentence. )

2. The transition from global to Asian data is abrupt. Adding a bridging sentence would improve the flow (e.g., “This global trend is reflected in Asia, where…”). - Response (The transition was smoothed by adding a bridging sentence, as the reviewer mentioned. )

3. Ensure numerical comparisons are clear and impactful; for example, show percentage increases when comparing 2022 to 2023 arrest data.- Response (The numerical comparisons were re-reported in an impactful manner.)

4. Some phrasings are redundant (e.g., “widespread effects that are multifaceted and interrelated…” could be simplified).- Response (The phrase “widespread effects that are multifaceted and interrelated” has been streamlined to “affects individuals across physical, psychological, and social domains,” which is more concise yet retains the full meaning. Other slight adjustments enhance flow and eliminate minor redundancy (e.g., avoiding unnecessary repetition of "users also reported...")

5. When citing multiple sources, consider combining them for readability. -Response (The changes are made in identified areas. )

6. The rationale for the study could be clearer: specify how this study will explore local motivations in depth.- Response (The rationale was clearly and comprehensively mentioned, which emphasizes the lack of community-based, qualitative research.)

7. The research gap paragraph should be more assertive: e.g., “Despite rising prevalence, there is a critical lack of detailed, community-based research…” - Response (The research gap was rephrased more assertively. )

8. Split the aim statement into clear, bullet-pointed objectives for easy reading.-Response (As the reviewers commented, the aim statement was split and bullet-pointed separately.)

9. Minor grammatical edits: use “aged 12 or older” instead of “age 12 or older”; merge repetitive sentences for conciseness.- Response (The grammatical mistake was corrected as aged 12 or more.)

Methods:

10. Important details on sampling and recruitment procedures are missing. How were participants identified and selected? - Response (Detailed how participants were identified and selected.)

11. Use consistent past tense for the study design description. Avoid repetition when describing the setting.-Response (The description of the setting was paraphrased, and repetitions were removed, and the tense was corrected.)

12. Clarify how DSM-5 diagnoses were confirmed — by whom and based on what process?- Response (Clarified who confirmed DSM-5 diagnoses and how. “”as confirmed by consultant psychiatrists or trained psychiatric medical officers using structured clinical interviews and medical records”)

13. Explain how withdrawal symptoms were identified and excluded during recruitment. - Response (Withdrawal symptoms were identified through medical records and clinical observation by attending clinicians before recruitment.)

14. Confirm that the source for the DSM-5 criteria is cited correctly.- Response (Re-checked the citation.

“American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. “ )

15. For the pattern-of-use questions, indicate whether these items were validated or developed by the authors. If the author developed, how were they pre-tested and improved? - Response ( This one is author developed (self developed). At the end of the data collection tool, all validation methods, including content validity and pretest, were already described. )

16. You mention open-ended questions but do not explain how responses were coded and analyzed — this should be described briefly.- Response (Described at the end of the data analysis )

17. Good to note the pre-test and Cronbach’s alpha; specify how feedback from the pre-test informed final revisions- Response (We have updated the methodology section to clarify that participant feedback during the pre-test focused on item clarity and wording. Based on this input, minor revisions were made to simplify the language and improve understanding of key items, particularly those related to the frequency of use and psychological effects. Cronbach's alpha for 11 11-item scale is already mentioned.)

18. In data collection, mention how many interviewers were involved and whether inter-rater reliability was checked. - Response (It was already mentioned as “Data were collected by four investigators who had undergone training,…….”

It was measured by kappa values)

19. In data analysis, clarify that only descriptive statistics were planned if no inferential analysis was done; explain how missing data were handled. - Response (No missing data were observed within the data sheet)

20. Ensure consistent tense and phrasing: e.g., “due to the population represents…” should be “because the population represents…”- Response (This wording is corrected. )

21. It is not clear why the data was only analyzed descriptively. Rigorous data analysis would benefit the study. what confounding factors were detected, and how were they controlled? - Response (Thank you for this important observation. This study was intentionally designed as a descriptive cross-sectional study with the primary aim of exploring the patterns, severity, and perceived impacts of methamphetamine addiction among a clinical population. Since there is a paucity of baseline data in this context, particularly regarding MA addiction and its psychosocial correlates, the study sought to first generate foundational insights rather than test specific hypotheses.

Given that the study focused on perceived impact rather than causal inference, and that variables such as addiction severity were not manipulated or independently controlled, adjustment for confounding was not applicable within this design. Moreover, many variables were exploratory and based on patient perception, making them less suitable for inferential analysis without validated outcome measures. We fully agree that future research should incorporate analytical designs such as cohort studies or regression-based modeling to identify predictors, control confounding factors, and determine statistically significant relationships.

This study will be a baseline study for future research.)

Results:

22. It is unclear why “Muslim” is classified as an ethnicity rather than a religious group — please clarify or adjust the categorization. - Response (In this study, the term Muslim is changed to “Moor” to refer to the ethnic group commonly known as Sri Lankan Moors, who are predominantly Muslim by religion. While “Muslim” is often used interchangeably in local discourse, it primarily denotes religious affiliation. To avoid conflation of ethnicity and religion, and in alignment with national census classifications, the term “Moor” has been adopted to represent this ethnic group.)

23. The education level categories (primary, secondary, tertiary, higher, vocational) are not clearly defined — consider aligning with standard classifications. - Response (In Sri Lanka, the education level is categorized as primary education (grades 1 to 5), secondary education (grades 6 to Advanced level), tertiary (concurrently used as higher ) education (undergraduate and/or postgraduate), and vocational and technical education.

The necessary changes were made in the table, and put a foot note to the table )

24.Use the consistent past tense when reporting results.- Response (The consistency was maintained throughout the results section)

25. Ensure small percentages are formatted consistently.- Response (All percentage was rounded up to two decimal points.)

26. Tables are generally well-structured, but check for decimal alignment. Clarify in the polydrug use table that multiple responses were possible.- Response (Decimal correction was made in the tables.

We have clarified in the text and that multiple responses were possible among polydrug users. This ensures that the reader understands the percentages may exceed 100% due to overlapping substance use.)

27. Heatmaps should be correctly labeled in the text as “Figure 1A,” “Figure 1B,” etc., and figures should be cross-referenced appropriately. - Response (The figures are cross-referred as advised. )

28. When reporting severity and patterns, add a line to interpret what the distribution implies. - Response (A new sentence was added to imply the distribution overall.)

29. Small details: use “Separated” instead of “Separate” for social status. - Response (Correct the word as separated.)

30. Clarify the overlap between similar items such as “isolation from family” and “lack of family closeness.” - Response (Thank you for your observation. While these items may appear similar, they address distinct aspects of familial relationships. “Isolation from family” refers to the behavioral or physical separation from family members, such as not living with them, avoiding contact, or being excluded from family activities. In contrast, “lack of family closeness” captures the emotional dimension specifically, the absence of warmth, trust, or supportive bonds even when regular contact exists. To clarify the conceptual distinction between these two items, we have added a footnote below the relevant table.)

31. Briefly interpret the significance of polydrug use and social impacts to guide the reader’s understanding. - Response (A brief sentence is added to emphasize the significance of this finding under the results section. In the discussion, this matter was discussed. )

Discussion:

32. The Discussion should more clearly compare the study’s findings with previous research, highlighting reasons for similarities and differences.- Response (While appreciating the reviewer’s insightful suggestion, we acknowledge the importance of situating our findings within the context of existing literature. However, as methamphetamine (MA) addiction, particularly in the Sri Lankan context, has received limited scholarly attention, there was a scarcity of directly comparable studies. Despite this limitation, we made every effort to integrate and critically engage with the available national and international literature relevant to substance use patterns, influence, and associated impacts. Where direct comparisons were not possible due to contextual or thematic gaps in prior research, we highlighted the novelty and significance of our findings and their implications for future studies and interventions. )

33. Some points are repeated unnecessarily (e.g., male predominance, cultural stigma, physical impacts). Combine these for conciseness.- Response ( Upon careful review of the manuscript, we found that while some related ideas were mentioned in multiple sections for thematic clarity, unnecessary repetition was minimal. However, to improve conciseness and flow, we have made targeted edits to streamline overlapping content)

34. Expand on the implications of polydrug use for treatment planning, withdrawal management, and relapse prevention in local contexts. - Response (The implications of polydrug use are expanded for clear understanding. )

35. For physical impacts, tie findings to specific clinical consequences (e.g., the need for nutritional or dental interventions). - Response (Necessary changes are made aligns with the comment. )

36. When citing other studies, integrate citations meaningfully: show how your results align with or differ from theirs.- Response ( As methamphetamine addiction, particularly in the Sri Lankan and Asian context, remains a significantly under-researched area, we encountered a scarcity of directly comparable studies that align closely with our findings. As such, in many instances, it was challenging to draw clear cut comparisons between our results and existing literature. However, where relevant data were available we have revised the discussion to integrate those citations more meaningfully by explicitly noting similarities or distinctions. These revisions aim to enhance the contextual relevance and interpretive clarity of our findings within the broader evidence base.)

37. Limitations are acknowledged but could be stronger: note the reliance on self-reported data, the potential for under- or over-reporting, and the lack of generalizability due t

Attachment

Submitted filename: Response to Reviewer.pdf

pone.0326469.s003.pdf (263.3KB, pdf)

Decision Letter 1

Nicholas Aderinto Oluwaseyi

28 Aug 2025

Dear Dr. Sriyani,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Nicholas Aderinto Oluwaseyi

Academic Editor

PLOS ONE

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Reviewer #2:

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: Comments to the Editor

Dear Editor,

Thank you for the opportunity to review this manuscript. The authors address an urgent and underexplored public health issue—methamphetamine addiction in Sri Lanka—using a descriptive cross-sectional design. The manuscript makes a valuable contribution by presenting primary clinical data from the National Institute of Mental Health, the country’s leading treatment center. The large sample size (n=427), high response rate, and comprehensive exploration of perceived physical, psychological, and social impacts are commendable.

However, while the manuscript highlights an important issue, several methodological and interpretive limitations reduce its scientific rigor. Minor revisions are required to strengthen the study before it is suitable for publication.

Comments

How were open-ended responses systematically coded (beyond thematic grouping)?

Was the DSM-5 checklist interviewer-administered or self-reported?

The reported Cronbach’s alpha (0.89) applies only to severity items, not the entire instrument. Reliability and validity of other sections remain unclear.

Addiction severity is classified according to DSM-5 symptom count, but it is unclear whether clinicians verified responses or whether lay interviewers applied criteria.

Misclassification risk should be acknowledged.

The analysis is largely descriptive. Inferential or multivariate analyses (e.g., associations between demographics and severity) could provide greater depth.

No adjustment for multiple testing is reported, despite numerous outcome measures. This raises concern about inflated type I error.

The manuscript often implies causality (e.g., “methamphetamine causes family separation”) despite the cross-sectional design. The authors should temper causal language.

The very high rate of polydrug use (87%) is striking but insufficiently discussed. How does this affect interpretation of methamphetamine-specific impacts? Many “perceived impacts” may be attributable to multiple substances.

Strengths and limitations should be presented more systematically. Currently, limitations are underplayed.

Several grammatical and typographical errors reduce clarity (e.g., “boos energy” → “boost energy”; “ticket the box” → “ticked the box”).

Figures/heatmaps are visually appealing but need clearer legends and consistency in labeling.

Conclusions should align more closely with the descriptive nature of the study and avoid policy overreach without stronger evidence.

Recommendation

This manuscript provides much-needed data on methamphetamine use in Sri Lanka. However, methodological weaknesses (sampling, measurement, analysis) and interpretive overstatements must be addressed to improve validity and impact. With substantial revision, the paper has the potential to make a meaningful contribution to the literature on substance use in South Asia.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: Yes:  Ngozika Esther Ezinne

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2026 Jan 13;21(1):e0326469. doi: 10.1371/journal.pone.0326469.r004

Author response to Decision Letter 2


5 Oct 2025

1. How were open-ended responses systematically coded (beyond thematic grouping)?-Open-ended responses were systematically analyzed using an inductive thematic coding approach. Initial codes were generated directly from the data and refined through iterative reading. Two independent researchers applied the codes, and any discrepancies were resolved through discussion, with a third researcher providing arbitration when required. The finalized codes were then organized hierarchically into broader themes and categories, which allowed for systematic identification of patterns across responses beyond simple grouping.

2. Was the DSM-5 checklist interviewer-administered or self-reported?-DSM-5 assessment was the 2nd section of the questionnaire. Initially, we mentioned that the whole questionnaire was interviewer-administered. Therefore, the DSM-5 checklist is interviewer-administered.

3. The reported Cronbach’s alpha (0.89) applies only to severity items, not the entire instrument. The reliability and validity of other sections remain unclear.-We appreciate the reviewer’s comment regarding the reliability analysis of the 10-item scale assessing reasons for MA use. Cronbach’s alpha was calculated, but the result was negative. This occurs because Cronbach’s alpha assumes that all items measure a single underlying construct (unidimensionality) and are positively correlated [1]. In our questionnaire, the 10 items represent distinct reasons for MA use, which are conceptually different and not necessarily expected to correlate positively. Therefore, Cronbach’s alpha is not an appropriate measure of internal consistency for this type of checklist.

Instead of relying on alpha, we examined the face and content validity of the items, ensuring each item captures a unique and relevant reason for MA use, and used descriptive statistics to report their prevalence. This approach is consistent with prior studies using similar “reason checklists” in substance use research.

[1]

4. Addiction severity is classified according to DSM-5 symptom count, but it is unclear whether clinicians verified responses or whether lay interviewers applied criteria.

Misclassification risk should be acknowledged. -We thank the reviewer for the comment regarding the potential for misclassification. In our study, all participants were clinically diagnosed with methamphetamine use disorder according to DSM-5 criteria by consultant psychiatrists or psychiatric medical officers using structured clinical interviews and medical records. Therefore, the risk of misclassification is minimized as diagnoses were clinician-verified rather than relying solely on self-report.

5. The analysis is largely descriptive. Inferential or multivariate analyses (e.g., associations between demographics and severity) could provide greater depth. -Associated factors were calculated using chi-square and likelihood ratios.

Findings were discussed in the discussion.

6. No adjustment for multiple testing is reported, despite numerous outcome measures. This raises concern about inflated type I error.-Associated factors were calculated using chi-square and likelihood ratios.

Findings were discussed in the discussion. - A clarification has been added in the “Data Analysis” section explaining that the study’s descriptive intent did not require adjustment for multiple comparisons, and results were interpreted accordingly [2]

7. The manuscript often implies causality (e.g., “methamphetamine causes family separation”) despite the cross-sectional design. The authors should temper causal language.-Accordingly, we carefully reviewed the entire Discussion section and rephrased all statements that implied causation to reflect associations instead.

8. The very high rate of polydrug use (87%) is striking but insufficiently discussed. How does this affect the interpretation of methamphetamine-specific impacts? Many “perceived impacts” may be attributable to multiple substances.-We have expanded the discussion to address how the high prevalence of polydrug use complicates the interpretation of methamphetamine-specific effects. A new paragraph has been added (highlighted in the revised manuscript) explaining the potential confounding influence of concurrent substance use and the need for future studies to isolate methamphetamine-related outcomes

9. Strengths and limitations should be presented more systematically. Currently, limitations are underplayed.- We revised the “Strengths and Limitations” section to systematically acknowledge study design, sampling, and measurement limitations, emphasizing their implications for interpretation.

10. Several grammatical and typographical errors reduce clarity (e.g., “boos energy” → “boost energy”; “ticket the box” → “ticked the box”).- All are corrected as necessary.

11. Figures/heatmaps are visually appealing but need clearer legends and consistency in labeling.-The figure reporting consistency was rearranged, and the legends now clearly illustrating the meaning of the figure.

12. Conclusions should align more closely with the descriptive nature of the study and avoid policy overreach without stronger evidence. -The conclusion has been rewritten to reflect the basic analytical nature of the study and to avoid policy overreach, focusing instead on evidence-informed implications.

Attachment

Submitted filename: Table of comment.docx

pone.0326469.s004.docx (35.9KB, docx)

Decision Letter 2

Nicholas Aderinto Oluwaseyi

2 Nov 2025

Dear Dr. Sriyani,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Nicholas Aderinto Oluwaseyi

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: Authors revision of the manuscript has helped to improve the quality but I still have few comments.

1. Study design & claims

• The paper repeatedly infers or implies determinants of severity from cross-sectional and largely descriptive/bivariate data. Causality cannot be inferred. Please re-frame throughout as associations among treated in-patients/outpatients at NIMH.

2. Target condition & measurement

• Diagnostic ascertainment is described as “DSM-5 criteria confirmed by consultant psychiatrists or psychiatric medical officers using structured clinical interviews and medical records” but the specific instrument (e.g., SCID-5, MINI) is not named. Please specify the instrument(s), training, version, languages, and whether inter-rater calibration was conducted.

• Severity scoring: DSM-5 SUD severity (2–3 mild, 4–5 moderate, 6–11 severe) is a categorical rubric for diagnosis, not a psychometric scale. Reporting Cronbach’s α=0.89 on DSM-5 symptom items is not appropriate (the criteria are formative/diagnostic, not reflective indicators). Remove α for DSM-5 items; if you retain reliability analyses, do so only for any new multi-item scales designed to measure a single latent construct.

• Perceived impacts: Open-ended responses were coded thematically, but the codebook, exemplar quotes, intercoder reliability for each domain, and denominator handling (multiple responses permitted) are not reported. Provide: (i) codebook in Supplement, (ii) examples per theme, (iii) how you calculated percentages (per total N vs. per respondents endorsing any item), and (iv) κ per key code if feasible.

3. Polydrug use as a confounder

• With 87% reporting polydrug use, nearly all “impacts” and “associations with severity” are plausibly confounded. Current analyses do not adjust for concurrent alcohol, cannabis, heroin, or tobacco. You should:

o Present stratified descriptives by polydrug vs. methamphetamine-only.

o Include polydrug use indicators in multivariable models (see below) or conduct sensitivity analyses excluding heavy polydrug users.

4. Statistical analysis—move beyond bivariate tests

• The table “Associated factors for Methamphetamine use severity” is based on χ²/Fisher’s tests only. To support statements such as “severity was associated with…”, perform multivariable modeling:

o Primary: Ordinal logistic regression (proportional odds) with severity (mild/moderate/severe) as outcome; test proportional-odds assumption (e.g., Brant test). If violated, use multinomial logistic regression.

o Covariates: age, sex, education, income, living area, living arrangement, age of onset, frequency, route, accessibility, and polydrug indicators. Consider province fixed effects.

o Report adjusted odds ratios with 95% CIs and model fit (pseudo-R², likelihood ratio tests).

o Provide effect sizes for bivariate tests (e.g., Cramér’s V) even if you keep the table.

• Multiple testing: You state no correction was applied. Either prespecify a primary model and outcomes to mitigate multiplicity, or apply FDR/Bonferroni for the large number of comparisons, and explicitly mark adjusted p-values.

• Some internal inconsistencies appear (see Minor comments). Please audit all frequencies and denominators.

6. Figures & tables—clarity and reproducibility

• Heatmaps are visually engaging but readers need numerical tables (counts and percentages) in the main text or Supplement for each impact domain. State clearly that items were multiple-response and give the exact denominator used for each percent.

• Table footnotes should define all categories (e.g., “Urban/Semi-urban/Rural” operationalization; “Isolation from family” vs. “lack of family closeness”). Ensure consistent capitalization (use “methamphetamine” not capitalized unless sentence-initial).

• Standardize decimal precision (e.g., one decimal place for percentages) and align counts (n, %).

7. Interpretation & positioning

• Some narrative sections over-generalize to the population of Sri Lanka or suggest policy effects beyond the sampling frame. Re-anchor claims to treatment-seeking adults at NIMH.

• Where your findings diverge from international literature (e.g., higher income and urban residence associated with greater severity), propose contextual hypotheses and acknowledge alternative explanations (clinic catchment, enforcement patterns, access/affordability, reporting bias).

8. Ethics & participant capacity

• You excluded “acute intoxication/withdrawal” and “cognitive impairment,” relying on clinicians’ judgment. State how capacity to consent was assessed (beyond “coherent, alert, oriented”) and whether interpreters were used for non-Sinhala/Tamil speakers. Confirm whether participation affected care in any way (it should not). Consider adding a distress protocol for participants reporting suicidal ideation.

9. Language & stigma

• Use “methamphetamine” (lowercase) consistently; reserve “ICE” to a footnote and avoid slang in academic prose.

Minor comments (presentation & housekeeping)

Title & keywords

• Title is long and partially duplicated; consider: “Methamphetamine use disorder, perceived impacts, and associated factors among adults receiving care at Sri Lanka’s National Institute of Mental Health: an analytical cross-sectional study.”

• Add keywords reflecting methods (e.g., “polydrug use,” “ordinal logistic regression,” “South Asia”).

Abstract

• include design, setting, sample, main analysis (and specify that only bivariate tests were used if multivariable is not added), principal adjusted results (after you add models),

• Methods—instrument details

• Provide the full questionnaire (English + translated versions) as Supplementary File with source citations for borrowed items and the exact DSM-5 item prompts used.

• Clarify how accessibility and frequency were operationalized and whether recall periods were specified.

Results—consistency

• In Table 1, present n (%) consistently for all rows. Some rows show only % in text and n in table headings. Verify “Living with whom—other” count (9) vs. severity table shows “other 0” in mild category row; check alignment.

• A few typographical issues: stray commas/spaces, inconsistent hyphenation (semi-urban vs semi urban), and inconsistent province capitalization.

Figures

• Ensure figure captions define color scales, denominators, and that each heatmap is reproducible from the provided counts.

References

• Some duplicates (“World Drug Report 2020” listed twice as 1 and 3). Several references are not ideal primary sources for mechanistic claims (e.g., American Addiction Centers webpage). Replace with peer-reviewed or UNODC/WHO technical documents where possible.

• Check numbering order vs. first citation order; ensure in-text numbers match.

Suggested analytic upgrades (concrete)

1. Primary model: Ordinal logistic regression with severity (0=mild, 1=moderate, 2=severe). Predictors: age (continuous), sex, education, income (quintiles), living area, living arrangement, age of onset (categorical), frequency (ordinal), route (dummy variables), perceived accessibility (ordinal), polydrug indicators (alcohol, cannabis, heroin, tobacco, other), and province.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Jan 13;21(1):e0326469. doi: 10.1371/journal.pone.0326469.r006

Author response to Decision Letter 3


13 Dec 2025

The paper repeatedly infers or implies determinants of severity from cross-sectional and largely descriptive/bivariate data. Causality cannot be inferred. Please re-frame throughout as associations among treated in-patients/outpatients at NIMH.-Thank you for this important observation. We acknowledge that our cross-sectional design and descriptive/bivariate analyses do not permit causal inferences. We have revised the manuscript to remove any causal language and now describe the findings strictly as associations among treatment-seeking in-patients and out-patients at NIMH. All relevant sections have been updated accordingly.

Diagnostic ascertainment is described as “DSM-5 criteria confirmed by consultant psychiatrists or psychiatric medical officers using structured clinical interviews and medical records” but the specific instrument (e.g., SCID-5, MINI) is not named. Please specify the instrument(s), training, version, languages, and whether inter-rater calibration was conducted. -Thank you for this valuable methodological clarification. We agree that the specification of the diagnostic instrument and procedures is essential for transparency and reproducibility. We have now clarified that DSM-5 diagnoses were established using routine structured clinical diagnostic interviews based on DSM-5 criteria conducted by consultant psychiatrists or trained psychiatric medical officers, rather than a standardized research interview such as SCID-5 or MINI. These clinicians were formally trained in DSM-5 diagnostic assessment as part of their postgraduate psychiatric training and routine clinical practice. Diagnoses were further verified through medical record review.

The diagnostic interviews were conducted in Sinhala and Tamil, depending on participant preference. As the diagnosis was made as part of routine clinical care prior to recruitment, formal inter-rater calibration between psychiatrists was not conducted for the purpose of this study.

Severity scoring: DSM-5 SUD severity (2–3 mild, 4–5 moderate, 6–11 severe) is a categorical rubric for diagnosis, not a psychometric scale. Reporting Cronbach’s α=0.89 on DSM-5 symptom items is not appropriate (the criteria are formative/diagnostic, not reflective indicators). Remove α for DSM-5 items; if you retain reliability analyses, do so only for any new multi-item scales designed to measure a single latent construct. This alpha was added based on the previous reviewers' comment only. Initially, this was not embedded. However, we have now removed this part.

Perceived impacts: Open-ended responses were coded thematically, but the codebook, exemplar quotes, intercoder reliability for each domain, and denominator handling (multiple responses permitted) are not reported. Provide: (i) codebook in Supplement, (ii) examples per theme, (iii) how you calculated percentages (per total N vs. per respondents endorsing any item), and (iv) κ per key code if feasible. The code book is provided in the supplementary file 1, and example quotes are provided in Supplementary file 2

Percentages for perceived impacts were calculated using the total sample (N = 427) as the denominator. Because multiple responses per participant were permitted, the summed percentages exceed 100%.

Overall interrater reliability was measured and k-= 0.82

Polydrug use as a confounder

• With 87% reporting polydrug use, nearly all “impacts” and “associations with severity” are plausibly confounded. Current analyses do not adjust for concurrent alcohol, cannabis, heroin, or tobacco. You should:

o Present stratified descriptives by polydrug vs. methamphetamine-only.

o Include polydrug use indicators in multivariable models (see below) or conduct sensitivity analyses excluding heavy polydrug users. we have now added a stratified descriptive analysis comparing methamphetamine-only users (n = 55) with polydrug users (n = 372) in the Results section.

The stratified findings show meaningful differences between groups. Notably, the proportion of severe addiction was higher among methamphetamine-only users (40.0%) compared to polydrug users (31.7%). Daily methamphetamine use was also more frequent among methamphetamine-only users (41.8%) relative to polydrug users (26.7%). These results demonstrate that high severity and frequent use are not solely attributable to concurrent substance use.

We also revised the Discussion to clearly acknowledge the potential confounding effects of polydrug use and to interpret the findings in light of these stratified patterns.

Given the descriptive and exploratory objectives of the study, and because inferential modelling was not planned in the original protocol, we did not add multivariable analyses. Instead, we believe the stratified results provide a transparent and methodologically appropriate way to address the reviewer’s concern.

Statistical analysis—move beyond bivariate tests

• The table “Associated factors for Methamphetamine use severity” is based on χ²/Fisher’s tests only. To support statements such as “severity was associated with…”, perform multivariable modeling:

o Primary: Ordinal logistic regression (proportional odds) with severity (mild/moderate/severe) as outcome; test proportional-odds assumption (e.g., Brant test). If violated, use multinomial logistic regression.

o Covariates: age, sex, education, income, living area, living arrangement, age of onset, frequency, route, accessibility, and polydrug indicators. Consider province fixed effects.

o Report adjusted odds ratios with 95% CIs and model fit (pseudo-R², likelihood ratio tests).

o Provide effect sizes for bivariate tests (e.g., Cramér’s V) even if you keep the table.

• Multiple testing: You state no correction was applied. Either prespecify a primary model and outcomes to mitigate multiplicity, or apply FDR/Bonferroni for the large number of comparisons, and explicitly mark adjusted p-values.

• Some internal inconsistencies appear (see Minor comments). Please audit all frequencies and denominators.

6. Figures & tables—clarity and reproducibility

• Heatmaps are visually engaging but readers need numerical tables (counts and percentages) in the main text or Supplement for each impact domain. State clearly that items were multiple-response and give the exact denominator used for each percent. We appreciate the value of multivariable modelling in explanatory epidemiological work. However, after careful consideration, we respectfully maintain that multivariable regression is not appropriate, not feasible, and not aligned with the purpose, design, or approved protocol of our study. We provide a detailed justification below, along with the substantial improvements we have incorporated based on the reviewer’s feedback.

Our Study Objectives and Design Do Not Justify Multivariable Modelling

Our study was explicitly designed as a descriptive and exploratory cross-sectional study, focusing on:

1. Describing patterns and severity of methamphetamine use

2. Identifying the prevalence and types of polydrug use

3. documenting perceived physical, psychological, and social impacts

4. Exploring bivariate associations between severity and selected factors

The study was not designed to test a predictive model or quantify adjusted relationships. Therefore, adding multivariable logistic or ordinal regression analyses would constitute a major analytic shift beyond our prespecified aims and could introduce inappropriate causal interpretations.

This statistical approach was included in the study protocol approved by the Ethics Review Committee, and deviating from it would reduce methodological transparency and violate the principle of prospectively defined analysis.

Our Dataset Is Not Suitable for Multivariable Modelling

The reviewer’s proposed model includes over 10 covariates, including several with extremely low cell counts:

• Injection route

• Swallowing route

• Female sex

• Some income and province categories with sparse frequencies

Such sparse distributions violate assumptions of:

• logistic regression

• multinomial/ordinal models

• proportional-odds testing

• stability of coefficient estimation

This would lead to:

• convergence failures

• inflated standard errors

• unstable/meaningless adjusted odds ratios

• risk of overfitting (events-per-variable ratio too low)

Thus, a multivariable model would not be statistically valid or informative for this dataset.

Further Multivariable regression inherently suggests, causal inference, or predictive modelling.

Neither is appropriate for self-reported, cross-sectional data affected by:

• recall bias

• high collinearity across behavioral exposures

• extremely high prevalence of polydrug use (87%)

• overlapping psychosocial determinants

Introducing adjusted models may unintentionally lead readers to infer causal relationships, which is not supported by this study’s design.

We respectfully clarify that multiplicity corrections (Bonferroni/FDR) are not appropriate in exploratory descriptive studies where the purpose is not hypothesis testing, but pattern identification.

Instead, we explicitly state:

• No correction for multiple testing was applied because the study is exploratory.

• Findings are interpreted cautiously, with emphasis on pattern consistency rather than p-values.

This approach aligns with current recommendations for descriptive observational research

Table footnotes should define all categories (e.g., “Urban/Semi-urban/Rural” operationalization; “Isolation from family” vs. “lack of family closeness”).

Ensure consistent capitalization (use “methamphetamine” not capitalized unless sentence-initial). We agree that clearer operational definitions improve the interpretability of the tables. We have now added explicit footnotes defining all relevant categories, including “Urban/Semi-urban/Rural” and the distinctions between “Isolation from family,” “Lack of family closeness,” and other family-related variables. These definitions are now provided directly beneath the relevant tables to ensure clarity for readers.

Corrected

Standardize decimal precision (e.g., one decimal place for percentages) and align counts (n, %). Thank you for this helpful suggestion. We have now standardized decimal precision throughout the manuscript. Percentages are presented to one decimal place, and counts (n, %) are aligned consistently across all tables and text (e.g., changed from 37.24% to 37.2%). These revisions have been applied to ensure clarity and consistency as recommended.

Some narrative sections over-generalize to the population of Sri Lanka or suggest policy effects beyond the sampling frame. Re-anchor claims to treatment-seeking adults at NIMH. Thank you for this comment. We have revised the paragraph to avoid any generalizations to the broader Sri Lankan population or implications for national policy. The revised text now focuses solely on the experiences of treatment-seeking adults at NIMH and interprets easy accessibility as relevant only to this group. We also removed prescriptive statements about regulatory or enforcement measures.

Where your findings diverge from international literature (e.g., higher income and urban residence associated with greater severity), propose contextual hypotheses and acknowledge alternative explanations (clinic catchment, enforcement patterns, access/affordability, reporting bias). Thank you for this comment. We have revised the text to include contextual explanations for why higher income and urban residence were associated with greater severity in our sample and have acknowledged alternative explanations such as clinic catchment patterns, enforcement activity, access and affordability, and possible reporting biases. We also reworded the paragraph to avoid causal language and anchor the interpretation to treatment-seeking adults at NIMH.

You excluded “acute intoxication/withdrawal” and “cognitive impairment,” relying on clinicians’ judgment. State how capacity to consent was assessed (beyond “coherent, alert, oriented”) and whether interpreters were used for non-Sinhala/Tamil speakers. Confirm whether participation affected care in any way (it should not). Consider adding a distress protocol for participants reporting suicidal ideation.

We have now expanded the description of our consent and ethical procedures. Capacity to consent was evaluated using a structured assessment in addition to clinicians’ judgment. We added details on interpreter use for participants who did not primarily speak Sinhala or Tamil, confirmed that participation had no effect on clinical care, and described the distress protocol used for participants expressing psychological distress or suicidal ideation.

Use “methamphetamine” (lowercase) consistently; reserve “ICE” to a footnote and avoid slang in academic prose. The term “methamphetamine” is used consistently throughout the manuscript. The colloquial term “ICE” is mentioned only once in a footnote to clarify local terminology among users.

Title is long and partially duplicated; consider: “Methamphetamine use disorder, perceived impacts, and associated factors among adults receiving care at Sri Lanka’s National Institute of Mental Health: an analytical cross-sectional study.” Corrected

Add keywords reflecting methods (e.g., “polydrug use,” “ordinal logistic regression,” “South Asia”). Added

Abstract

• include design, setting, sample, main analysis (and specify that only bivariate tests were used if multivariable is not added), principal adjusted results (after you add models),

• Methods—instrument details Study design, sample and sampling techniques, instrument details are already there.

Study setting was added.

Provide the full questionnaire (English + translated versions) as Supplementary File with source citations for borrowed items and the exact DSM-5 item prompts used. The questionnaire used in this study will be provided by the corresponding author to interested readers upon reasonable request.

Clarify how accessibility and frequency were operationalized and whether recall periods were specified. We clarified the frequency and accessibility in foot note.

No fixed recall window was imposed, as the study relied on participants’ typical pre-treatment usage pattern, consistent with the DSM-5 approach to evaluating substance use severity.

Results—consistency

• In Table 1, present n (%) consistently for all rows. Some rows show only % in text and n in table headings. Verify “Living with whom—other” count (9) vs. severity table shows “other 0” in mild category row; check alignment. In table O1, all n (%) are already included. No missing values

In the severity table, living with whom does not imply.

A few typographical issues: stray commas/spaces, inconsistent hyphenation (semi-urban vs semi urban), and inconsistent province capitalization. Corrected

Figures

• Ensure figure captions define color scales, denominators, and that each heatmap is reproducible from the provided counts. Figure legends clearly indicate the variability.

Generally, in the heatmap, all colour codes do not need to be defined. Instead the standard figure legend is already there by mentioning “with color gradients representing the percentage of perceived symptoms. Darker colors indicate a higher percentage of self-reported social impact, while lighter colors indicate a lower percentage of perceived effects.”

Some duplicates (“World Drug Report 2020” listed twice as 1 and 3). Several references are not ideal primary sources for mechanistic claims (e.g., American Addiction Centers webpage). Replace with peer-reviewed or UNODC/WHO technical documents where possible.

• Check numbering order vs. first citation order; ensure in-text numbers match. All rechecked, and changes were done.

Attachment

Submitted filename: Response letter- Added.docx

pone.0326469.s005.docx (28.3KB, docx)

Decision Letter 3

Nicholas Aderinto Oluwaseyi

28 Dec 2025

Methamphetamine use disorder, perceived impacts, and associated factors among adults receiving care at Sri Lanka’s National Institute of Mental Health: An analytical cross-sectional study

PONE-D-25-28029R3

Dear Dr. Sriyani,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nicholas Aderinto Oluwaseyi

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: I do not have any further comments as authors have responded to all my comments. The quality of the manuscript has now improved.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

Acceptance letter

Nicholas Aderinto Oluwaseyi

PONE-D-25-28029R3

PLOS One

Dear Dr. Sriyani,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nicholas Aderinto Oluwaseyi

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. 1, 2, 3 codebook.

    (DOCX)

    pone.0326469.s001.docx (24.6KB, docx)
    S2 Table. 1, 2, 3 exemplar quotes.

    (DOCX)

    pone.0326469.s002.docx (18.6KB, docx)
    Attachment

    Submitted filename: Response to Reviewer.pdf

    pone.0326469.s003.pdf (263.3KB, pdf)
    Attachment

    Submitted filename: Table of comment.docx

    pone.0326469.s004.docx (35.9KB, docx)
    Attachment

    Submitted filename: Response letter- Added.docx

    pone.0326469.s005.docx (28.3KB, docx)

    Data Availability Statement

    All data files are available from the figshare database https://doi.org/10.6084/m9.figshare.29816636.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES